Search research articles
Contact Us
Filters
Showing results (181-190 of 222) with videos related to
Page
of 23
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2
Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Iscience
|
March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases
|
July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Nikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
Journal of Virology
|
June 27, 2014
Impaired Nef function is associated with early control of HIV-1 viremia
Xiaomei T Kuang, Xiaoguang Li, Gursev Anmole, et al.
Journal of Clinical and Translational Science
|
October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic
Maryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Journal of Clinical and Translational Science
|
November 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementation
Maryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Scott L Letendre, Huichao Chen, Ashley McKhann, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 222) with videos related to
Sort By:
Page
of 23
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2
Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Iscience
|
March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases
|
July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Nikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
Journal of Virology
|
June 27, 2014
Impaired Nef function is associated with early control of HIV-1 viremia
Xiaomei T Kuang, Xiaoguang Li, Gursev Anmole, et al.
Journal of Clinical and Translational Science
|
October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic
Maryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Journal of Clinical and Translational Science
|
November 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementation
Maryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Scott L Letendre, Huichao Chen, Ashley McKhann, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Page
of 23